Hc Biopharma Inc.
Clinical trials sponsored by Hc Biopharma Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo aims to control advanced lung cancer Results expected Dec 2026 (estimated)
- New hope for lung cancer: experimental drug HC010 enters phase 2 trial Results expected Dec 2026 (estimated)
- New lupus drug candidate enters early human safety testing Results expected Mar 2027 (estimated)
- Can a copy of a cancer antibody match the original in the body? Results expected Jun 2027 (estimated)